← Back to Search

Personalized Stress Management Techniques for Stress

Phase 2
Waitlist Available
Led By Karina Davidson, PhD, MASc
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ema pain will be assessed 3 times daily via text message during the baseline assessment period (2 weeks), during intervention period (12 weeks) and during follow-up period (4 weeks), 18 weeks total.
Awards & highlights

Summary

This trial tests meditation, yoga, and walking to help people manage stress. It focuses on individuals looking to reduce their stress levels. Participants will try each method to find out which one works best for them.

Who is the study for?
This trial is for adults in the U.S. who feel stressed, can wear a Fitbit, and use a smartphone. They must speak English and score at least 20 on the Perceived Stress Scale. It's not for those with severe illnesses, substance abuse history, upcoming surgeries, or advised against walking or yoga.
What is being tested?
The study tests if 'Personalized Trials' (guided meditation, yoga, brisk walking) tailored to individuals are better than standard stress management techniques. Participants will follow different sequences of these activities or choose without a set order.
What are the potential side effects?
Since this trial involves non-invasive stress management techniques like meditation, yoga, and walking rather than medication or medical procedures; side effects may include muscle soreness from physical activity but are generally minimal.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ema mood will be assessed 3 times daily via text message during the baseline assessment period (2 weeks), during intervention period (12 weeks) and during follow-up period (4 weeks), 18 weeks total.
This trial's timeline: 3 weeks for screening, Varies for treatment, and ema mood will be assessed 3 times daily via text message during the baseline assessment period (2 weeks), during intervention period (12 weeks) and during follow-up period (4 weeks), 18 weeks total. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Between-Arm Difference in Change in Ecological Momentary Assessment (EMA) of Stress.
Secondary study objectives
Agreement of Intervention Selection Between Participant and Researcher.
Change in Mean Within-Subject Difference in Weekly Perceived Stress.
Mean System Usability Score (SUS).
+7 more
Other study objectives
Descriptive Content of Qualitative Interview Data
Mean Fitbit Device Adherence Rate.
Mean Participant Ecological Momentary Assessment (EMA) adherence rate.
+7 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Personalized Trial CBAABCExperimental Treatment1 Intervention
Participants in Arm 2 will receive a Personalized Trial of the 3 stress management interventions in a CBAABC treatment order, where A=mindfulness meditation, B=yoga, and C=brisk walking. Participants in this arm will be prompted to complete 30-minute stress management sessions during applicable treatment weeks. A link to the stress management video will be delivered via text 3 times per week to the participant during applicable intervention periods in the personalized trial arms. Participants will be limited to three views of the study-provided stress management content each week.
Group II: Personalized Trial ABCCBAExperimental Treatment1 Intervention
Participants in Arm 1 will receive a Personalized Trial of the 3 stress management interventions in an ABCCBA treatment order, where A=mindfulness meditation, B=yoga, and C=brisk walking. Participants in this arm will be prompted to complete 30-minute stress management sessions during applicable treatment weeks. A link to the stress management video will be delivered via text 3 times per week to the participant during applicable intervention periods in the personalized trial arms. Participants will be limited to three views of study-provided stress management content each week.
Group III: Standard CareActive Control1 Intervention
Participants in Arm 3 will receive Standard Care of the 3 stress management techniques (mindfulness meditation, yoga, and brisk walking). Participants will receive access to the same number of views of the mindfulness meditation, yoga, and brisk walking content given to participants randomized in Arm 1 and Arm 2. However, they will not be prompted to complete any session according to a randomization sequence. A link to the stress management video will be delivered via text 1 time per week to the participant. Participants will be limited to 36 total views of study-provided stress management content (12 total views per stress management technique).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Personalized Trial ABCCBA
2022
Completed Phase 2
~220
Personalized Trial CBAABC
2022
Completed Phase 2
~220

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for stress management, such as guided mindfulness meditation, guided yoga, and guided brisk walking, work through different mechanisms to alleviate stress. Mindfulness meditation helps by promoting awareness and acceptance of the present moment, reducing the physiological and psychological impact of stress. Yoga combines physical postures, breathing exercises, and meditation to enhance physical flexibility, strength, and mental clarity, which collectively reduce stress levels. Brisk walking, a form of aerobic exercise, increases endorphin production, improves mood, and reduces anxiety. These treatments are important for stress patients as they offer non-pharmacological options that can be personalized to individual preferences and needs, potentially leading to better adherence and outcomes.
Mode-specific effects among three treatments for depression.

Find a Location

Who is running the clinical trial?

Columbia UniversityOTHER
1,471 Previous Clinical Trials
2,536,138 Total Patients Enrolled
National Library of Medicine (NLM)NIH
39 Previous Clinical Trials
107,271 Total Patients Enrolled
Northwell HealthLead Sponsor
473 Previous Clinical Trials
472,060 Total Patients Enrolled

Media Library

Personalized Trial ABCCBA Clinical Trial Eligibility Overview. Trial Name: NCT05408832 — Phase 2
Stress Research Study Groups: Personalized Trial CBAABC, Standard Care, Personalized Trial ABCCBA
Stress Clinical Trial 2023: Personalized Trial ABCCBA Highlights & Side Effects. Trial Name: NCT05408832 — Phase 2
Personalized Trial ABCCBA 2023 Treatment Timeline for Medical Study. Trial Name: NCT05408832 — Phase 2
~67 spots leftby Sep 2025